These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28558896)

  • 41. [Neuroleptic malignant syndrome: a review of literature].
    Crespo Facorro B; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(5):273-8. PubMed ID: 8553925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Persistent amnesia as a sequel of olanzapine-induced neuroleptic malignant syndrome.
    Mendhekar DN; Duggal HS
    J Neuropsychiatry Clin Neurosci; 2006; 18(4):552-3. PubMed ID: 17135384
    [No Abstract]   [Full Text] [Related]  

  • 43. Neuroleptic malignant syndrome with antidepressant/antipsychotic drug combination.
    Garcia G; Ghani S; Poveda RA; Dansky BL
    Ann Pharmacother; 2001 Jun; 35(6):784-5. PubMed ID: 11409001
    [No Abstract]   [Full Text] [Related]  

  • 44. Neuroleptic malignant syndrome induced by low dose aripiprazole in first episode psychosis.
    Evcimen H; Alici-Evcimen Y; Basil B; Mania I; Mathews M; Gorman JM
    J Psychiatr Pract; 2007 Mar; 13(2):117-9. PubMed ID: 17414689
    [No Abstract]   [Full Text] [Related]  

  • 45. A Case of neuroleptic malignant syndrome accompanied to an atypical antipsychotic agent: risperidone.
    Pasa S; Sayhan MB; Boyraz T; Urakci Z; Altintas A
    Neurotoxicology; 2008 Jul; 29(4):750-1. PubMed ID: 18539333
    [No Abstract]   [Full Text] [Related]  

  • 46. Advanced pediatric psychopharmacology.
    Vito J; Jummani R; Coffey B
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):498-502. PubMed ID: 16958576
    [No Abstract]   [Full Text] [Related]  

  • 47. Olanzapine-induced neuroleptic malignant syndrome with mental retardation.
    Margolese HC; Chouinard G
    Am J Psychiatry; 1999 Jul; 156(7):1115-6. PubMed ID: 10401467
    [No Abstract]   [Full Text] [Related]  

  • 48. Risperidone and neuroleptic malignant syndrome.
    Tarsy D
    JAMA; 1996 Feb; 275(6):446. PubMed ID: 8627964
    [No Abstract]   [Full Text] [Related]  

  • 49. Case report of neuroleptic malignant syndrome with prolonged mental changes and severe dyskinesia.
    Chung YJ; Lee SJ
    Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 29464897
    [No Abstract]   [Full Text] [Related]  

  • 50. [Malignant neuroleptic syndrome associated to risperidone].
    Aguirre C; García Monco JC; Mendibil B
    Med Clin (Barc); 1998 Feb; 110(6):239. PubMed ID: 9547739
    [No Abstract]   [Full Text] [Related]  

  • 51. Risk factors for the neuroleptic malignant syndrome.
    Kirkpatrick B; Edelsohn GA
    Psychiatr Med; 1984 Dec; 2(4):371-81. PubMed ID: 6152857
    [No Abstract]   [Full Text] [Related]  

  • 52. Neuroleptic malignant syndrome probably induced by asenapine.
    Raja S
    J Neuropsychiatry Clin Neurosci; 2014; 26(4):E36. PubMed ID: 26037883
    [No Abstract]   [Full Text] [Related]  

  • 53. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
    Illing M; Ancill R
    Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793
    [No Abstract]   [Full Text] [Related]  

  • 54. A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole.
    Rodriguez OP; Dowell MS
    J Okla State Med Assoc; 2006; 99(7):435-8. PubMed ID: 17017330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroleptic malignant syndrome while on tiapride treatment.
    Duarte J; Campos JM; Cabezas C; Sagredo V; Cortina J; Clavería LE
    Clin Neuropharmacol; 1996 Dec; 19(6):539-40. PubMed ID: 8937795
    [No Abstract]   [Full Text] [Related]  

  • 56. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T; Westendorp RG
    Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract]   [Full Text] [Related]  

  • 57. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
    Rock W; Elias M; Lev A; Saliba WR
    Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Possible paliperidone-induced neuroleptic malignant syndrome: a case report.
    Özdemir A; Aksoy-Poyraz C; Kılıç-Yener E
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):E22-3. PubMed ID: 23037666
    [No Abstract]   [Full Text] [Related]  

  • 59. 'Withdrawal neuroleptic malignant syndrome': a phantom explanatory cause for a fatality.
    Gillman PK
    Med Sci Law; 2011 Apr; 51(2):122-3; author reply 124. PubMed ID: 21793478
    [No Abstract]   [Full Text] [Related]  

  • 60. Olanzapine-induced atypical neuroleptic malignant syndrome in an adolescent man with anorexia nervosa.
    Ayyıldız H; Turan Ş; Gülcü D; Poyraz CA; Pehlivanoğlu E; Çullu F; Arıkan MK
    Eat Weight Disord; 2016 Jun; 21(2):309-11. PubMed ID: 26607823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.